GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (MIL:PHIL) » Definitions » 1-Year ROIIC %

Philogen SpA (MIL:PHIL) 1-Year ROIIC % : -1,544.07% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Philogen SpA's 1-Year ROIIC % for the quarter that ended in Jun. 2024 was -1,544.07%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Philogen SpA's 1-Year ROIIC % or its related term are showing as below:

MIL:PHIL's 1-Year ROIIC % is ranked worse than
94.16% of 1421 companies
in the Biotechnology industry
Industry Median: -11.22 vs MIL:PHIL: -1544.07

Philogen SpA 1-Year ROIIC % Historical Data

The historical data trend for Philogen SpA's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA 1-Year ROIIC % Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
- -84.43 540.57 -197.40

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only - 540.57 535.89 -197.40 -1,544.07

Competitive Comparison of Philogen SpA's 1-Year ROIIC %

For the Biotechnology subindustry, Philogen SpA's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philogen SpA's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Philogen SpA's 1-Year ROIIC % falls into.



Philogen SpA 1-Year ROIIC % Calculation

Philogen SpA's 1-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -31.7068 (Jun. 2024) - -0.2849 (Jun. 2023) )/( 32.676 (Jun. 2024) - 30.641 (Jun. 2023) )
=-31.4219/2.035
=-1,544.07%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Philogen SpA  (MIL:PHIL) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Philogen SpA 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Philogen SpA's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

From GuruFocus

Philux Global Group and Subsidiaries to Invest in Saigon Silicon City

By sperokesalga sperokesalga 02-27-2023

PHI Group, Inc. Acquires Majority Interest in Tin Thanh Group

By GlobeNewswire GlobeNewswire 08-19-2022